P-457 Docetaxel/gemcitabine vs. cisplatin/gemcitabine followed bydocetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): Results of a randomised phase II trial

Authors :: C. Schäper
C. Grah
D Binder
Bettina Temmesfeld-Wollbrück
Norbert Suttorp
H. Schweisfurth
G. Siebert
T. Beinert
Source :: Lung Cancer. 49:S236-S237
Publication Year :: 2005
Publisher :: Elsevier BV, 2005.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
Cancer Research
medicine.medical_specialty
business.industry
Docetaxel/Gemcitabine
non-small cell lung cancer (NSCLC)
medicine.disease
First line treatment
Internal medicine
Medicine
Cisplatin/gemcitabine
business

Full Text Access

Tools